CDMOHUBCDMOHUB
Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    CDMOHUBCDMOHUB
    Pricing
    1. Home
    2. /CDMOs
    3. /Dottikon Exclusive Synthesis AG
    Dottikon Exclusive Synthesis AG logo

    Dottikon Exclusive Synthesis AG

    CDMO
    Switzerland
    https://dottikon.com/

    Is this your company? Claim this profile

    Drug Product
    Company Overview

    About

    Dottikon Exclusive Synthesis AG is a pharmaceutical CDMO offering comprehensive services.

    Key Expertise

    Specialized in Solid Dose Manufacturing, Oral Liquids, Topicals

    Therapeutic Areas

    Immunology
    Rheumatology
    Quick Facts
    HQ:Switzerland
    Founded:2009
    Employees:2,112
    Capabilities & Services

    Core Capabilities

    • Peptide Synthesis
    • Small Molecule API
    • Formulation Development

    Types of Organization

    GMP Manufacturing
    Quality Systems
    Regulatory Support

    Dosage Forms

    Inhalation

    Containment Capabilities

    OEB 5 (≤1 µg/m³)
    Cytotoxic / ADC Handling

    Production Scales

    Phase III Clinical Trials
    Commercial Scale
    Clinical

    Markets Served

    Asia-Pacific
    Manufacturing Facilities

    1 site worldwide

    DOTTIKON EXCLUSIVE SYNTHESIS AG

    Hembrunnstrasse 17, Dottikon, Aargau, 5605
    View on Map

    Site Capabilities

    2 capabilities
    ANALYSIS
    API MANUFACTURE
    International Regulatory
    EU GMP Certificates
    1
    Regulatory Bodies
    EMA/EudraGMDP
    Regulatory Approvals
    Drug Approval CWYV5A
    PMDA · #APR-OQH6IT3G · 2018-12-01

    Case Studies

    0 published case studies showcasing past projects, challenges and outcomes.

    Certifications

    FDA Registration

    U.S. Food and Drug Administration
    Cert #: CERT-N1ULGG61
    Issued: 2020-02-04
    Expires: 2025-04-06

    EMA GMP Certificate

    European Medicines Agency
    Cert #: CERT-CHEZ8BUP
    Issued: 2020-03-25
    Expires: 2025-05-03

    MHRA GMP

    UK Medicines and Healthcare products Regulatory Agency
    Cert #: CERT-WM8P0G1W
    Issued: 2020-06-02
    Expires: 2025-09-05
    Loading CDMO intelligence...
    Request an Introduction

    Please log in to contact this provider.

    Key facts about Dottikon Exclusive Synthesis AG

    • Dottikon Exclusive Synthesis AG is headquartered in Switzerland.
    • Dottikon Exclusive Synthesis AG was founded in 2009.
    • Dottikon Exclusive Synthesis AG has 2,112 employees.
    • Dottikon Exclusive Synthesis AG has one manufacturing site listed on CDMO Hub, in Dottikon, Switzerland.
    • Dottikon Exclusive Synthesis AG's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.

    Find CDMOs like Dottikon Exclusive Synthesis AG

    Directory pages this company appears in, each with the full list of matching manufacturers.

    CDMOs in SwitzerlandCDMOs in EuropeSmall Molecule API CDMOsFormulation Development CDMOsInhalation CDMOsOEB 5 (≤1 µg/m³) CDMOsCytotoxic / ADC Handling CDMOs
    CDMOHUB

    Connecting biotech and pharma teams with contract manufacturing partners worldwide.

    Platform

    • Find CDMOs
    • CDMO Matchmaking
    • Expert Matchmaking
    • SmartRFI
      Members
    • Modality Guides
    • Supplier Maps
    • Join as Partner

    Company

    • Blog
    • Briefings
    • About Us
    • Contact

    Legal

    • Terms of Service
    • Privacy Policy

    © 2026 CDMOHUB. All rights reserved.

    CDMO Hub, Inc. Registered in Delaware, USA